Renee, Founder & Lead Researcher
Renee has led R3’s evidence-based analysis since 2024. Her work focus is on the "Toxicological Hazard Index" (THI) and benchmarking US products against international REACH standards.
- Specialization: Endocrine disrupting chemicals (EDCs) and developmental toxicology.
- Approach: Translating molecular research into actionable safety decision-support.